As already described in Section 3.1 and Section 3.2, Tkachev et al. (2023) suggested that SCH- and BD-associated changes in plasma lipidomic profiles are largely shared [50], and one of the main novel findings of the study was that alterations in Cer levels were characteristic for both BD and SCH patients. This evidence concerns the gene CBLN1 and spindle cell hemangioma.